spiperone has been researched along with cycloserine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Dall'Olio, R; Gandolfi, O; Rimondini, R | 1 |
2 other study(ies) available for spiperone and cycloserine
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
D-cycloserine decreases both D1 and D2 dopamine receptors number and their function in rat brain.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Cell Membrane; Cycloserine; Dizocilpine Maleate; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Ergolines; In Vitro Techniques; Kinetics; Male; Neostriatum; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Spiperone | 1994 |